Genmab — Februar 2015
-
Revlimid (lenalidomide) is a prescription medicine approved in combination with dexamethasone to treat patients with multiple myeloma (a type of cancer of the bone marrow) who already have had prior therapy. It is also approved to treat certain patients who have certain types of myelodysplastic syndromes (a group of conditions in which the bone marrow does not produce enough mature blood cells).
-
Styrken ved Dara er at den ser ud til at kunne kombineres med alle andre behandlinger i MM.
-
Jeg mener det var på ASCO14 at Len-dex fik prædikatet, "new standard of care" af nogle af pingerne. Hvis den kan overtrumfes med Dara-len-dex, så er vi godt på vej
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind